For Immediate Release
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has signed a non-government distribution agreement with Concordance Healthcare Solutions, one of the largest independent healthcare distributors in the U.S. Daxor and Concordance will work together to provide Daxor’s BVA-100® (Blood Volume Analyzer) diagnostic blood test to healthcare facilities nationally, driving the use of blood volume measurement to help guide precise, individualized volume management in a wide variety of medical conditions including heart failure and critical care.
“Partnering with Concordance will accelerate Daxor’s growing sales, allowing our technology to reach even more healthcare systems,” said Michael Feldschuh, Daxor’s CEO and President. “Combining our sales and marketing efforts will facilitate awareness, adoption and integration of our much-needed and valuable test into standard of care, leading to better outcomes and improvement of the quality of life for patients.”TIFFIN, OHIO– June 3, 2021. Concordance Healthcare Solutions LLC, one of the largest, independent, healthcare distributors in the U.S., is proud to announce they have been named to the 2020 Global Healthcare Exchange (GHX) Millennium Club. GHX announced the 63 healthcare provider and supplier organizations that harness automation to drive...
Implementing an approach that reduces the complexity of product sourcing, lessens the administrative workload for medical supplies procurement and serves to reduce product costs is possible through standardization. As enticing as it may be to allow individual healthcare personnel to choose the particular products they would like to use for their...